The Senate confirmation hearing for NCI Director Monica Bertagnolli, who has been nominated for the job of NIH director, has been scheduled for Oct. 18.
The University of Cincinnati Cancer Center was granted $2.3 million from NCI to develop a technique to visualize where genetically modified immune cells go in the body after being administered to patients with cancer.
